About A. Brian Mochon, PhD
Brian Mochon, PhD, is a pediatric clinical microbiologist who serves as the Director of Clinical Microbiology at Phoenix Children's. He specializes in the diagnosis of infectious diseases and antimicrobial susceptibility testing.
Dr. Mochon graduated with a Bachelor of Science in microbiology and molecular genetics from the University of California, Los Angeles (UCLA). After graduation, he worked as a public health microbiologist at the Orange County Public Health Laboratory in Santa Ana, California. It was during this time that he was inspired to return to school and pursue a doctorate in microbiology.
Dr. Mochon received a Master of Science in microbiology and immunology from Tulane University School of Medicine in New Orleans and finally a doctorate in biological sciences from the Department of Biological Chemistry at the University of California, Irvine, School of Medicine in California. Dr. Mochon then completed his fellowship training in medical and public health microbiology in the Department of Pathology and Laboratory Medicine at UCLA's David Geffen School of Medicine in Los Angeles. Prior to joining Phoenix Children's, Dr. Mochon served as the system medical director of clinical microbiology for a large integrated healthcare system.
Dr. Mochon is a diplomate of the American Board of Medical Microbiology. He also holds dual appointments in the Departments of Pathology and Child Health at the University of Arizona College of Medicine - Phoenix. Dr. Mochon has authored numerous peer-reviewed journal articles and chapters in medical textbooks. He also has served on several national professional committees for the American Society for Microbiology, the Clinical and Laboratory Standard Institute, and the Infectious Diseases Society of America, as well as an invited speaker and moderator at national medical conferences and meetings.
During his free time, Dr. Mochon enjoys backpacking, reading, traveling, and spending time with his wife and son.
Medical School / Education
University of California, Irvine (UCI) School of Medicine, Irvine, CA
Fellowship
(Medical and Public Health Microbiology) University of California, Los Angeles (UCLA) David Geffen School of Medicine, Los Angeles, CA
American Board of Medical Microbiology
Academic Affiliations
Departments of Pathology and Child Health, University of Arizona College of Medicine - Phoenix
Professional Affiliations
Member, American Society for Microbiology
Member, Infectious Diseases Society of America
Member, Clinical and Laboratory Standards Institute
Member, Valley Fever Center for Excellence, University of Arizona
Member, Arizona Department of Health Services, Antimicrobial Stewardship Subcommittee
John P, Shahbazian S, Lainhart WD, Hayes J, Mochon B, Nix DE. Risk for primary cephalosporin resistance in Gram-negative bacteremia. Antimicrobial Stewardship & Healthcare Epidemiology. 2023 Jan;3(1):e121.
Asempa TE, Bobenchik AM, Bourassa L, Clark AE, Hatch MT, Huse HK, Martin IW, Mochon AB, Munson E, Sfeir MM, Srodon M. Antimicrobial Activity of Tebipenem and Comparators against Enterobacterales from diverse Outpatient Centers and Nursing Homes in the United States. International Journal of Antimicrobial Agents. 2023 Mar 1;61(3):106733.
Lainhart W, Mochon AB, Pence MA, and Doern CD. Bacteriology, In: Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 7th ed., 2023.
Monroy-Nieto J, Bowers JR, Montfort P, Adame G, Taverna CG, Yaglom H, Sykes JE, Brady S, Mochon AB, Meyer W, Komatsu K. Phylogenomic Placement of American Southwest-Associated Clinical and Veterinary Isolates Expands Evidence for Distinct Cryptococcus gattii VGVI. Microorganisms. 2022 Aug 20;10(8):1681.
Bell ME, Sussland D, and Mochon AB. Section 8.3 - Media and Methods Used for Phenotypic Characterization of Aerobic Actinomycetes of Section 8 - Aerobic Actinomycetes, In: CA Burnham, Clinical Microbiology Procedures Handbook, 5th ed., Washington, DC: ASM Press, 2023.
Bell ME, Mochon AB, and Highlander SK. Section 8.4 - Definitive Identification of Aerobic Actinomycetes of Section 8 - Aerobic Actinomycetes, In: CA Burnham, Clinical Microbiology Procedures Handbook, 5th ed., Washington, DC: ASM Press, 2023.
Kobic E, Gill CM, Mochon AB, Nicolasora NP, Nicolau DP. Cefiderocol pharmacokinetics in a patient receiving continuous venovenous hemodiafiltration. In Open Forum Infectious Diseases 2021 Jul 1 (Vol. 8, No. 7, p. ofab252). US: Oxford University Press.
